[Ebola and Marburg viruses: the humans strike back] - PubMed

[Article in French]

Affiliations

• PMID: 16597410
• DOI: 10.1051/medsci/2006224405

Free article

Review

[Ebola and Marburg viruses: the humans strike back]

[Article in French]

Nathalie Alazard-Dany et al. Med Sci (Paris). 2006 Apr.

Free article

Abstract

Ebola and Marburg viruses are the causative agents of rapidly progressive hemorrhagic fevers with high mortality rates. Pre- or post-exposure treatments against the diseases are currently not available for human use. In the field, establishment of strict quarantine measures preventing further virus transmission are still the only way to fight the infections. However, our knowledge of Ebola and Marburg viruses has markedly increased as a result of two recent discoveries discussed in this review. Chandran et al. have elucidated the mechanism by which Ebola GP is converted to a fusion-active form. Infectivity of Ebola virus was shown to be dependent on the cleavage of GP by cellular endosomal proteases, cathepsin B and L, thus opening new therapeutic approaches options. As for Jones SM et al., they have successfully vaccinated monkeys with recombinant vesicular stomatitis virus expressing Ebola or Marburg virus surface glycoprotein GP, a promising vaccine approach.

Similar articles

• A single shot against Ebola and Marburg virus.

  Baize S. Baize S. Nat Med. 2005 Jul;11(7):720-1. doi: 10.1038/nm0705-720. Nat Med. 2005. PMID: 16015361 No abstract available.

• Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.

  Lehrer AT, Chuang E, Namekar M, Williams CA, Wong TAS, Lieberman MM, Granados A, Misamore J, Yalley-Ogunro J, Andersen H, Geisbert JB, Agans KN, Cross RW, Geisbert TW. Lehrer AT, et al. Front Immunol. 2021 Aug 18;12:703986. doi: 10.3389/fimmu.2021.703986. eCollection 2021. Front Immunol. 2021. PMID: 34484200 Free PMC article.

• Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.

  Geisbert TW, Feldmann H. Geisbert TW, et al. J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S1075-81. doi: 10.1093/infdis/jir349. J Infect Dis. 2011. PMID: 21987744 Free PMC article. Review.

• Emerging diseases. On the trail of Ebola and Marburg viruses.

  Balter M. Balter M. Science. 2000 Nov 3;290(5493):923-5. doi: 10.1126/science.290.5493.923. Science. 2000. PMID: 11184732 No abstract available.

• Ebola and Marburg virus vaccines.

  Reynolds P, Marzi A. Reynolds P, et al. Virus Genes. 2017 Aug;53(4):501-515. doi: 10.1007/s11262-017-1455-x. Epub 2017 Apr 26. Virus Genes. 2017. PMID: 28447193 Free PMC article. Review.

Cited by

• Strategies in Ebola virus disease (EVD) diagnostics at the point of care.

  Coarsey CT, Esiobu N, Narayanan R, Pavlovic M, Shafiee H, Asghar W. Coarsey CT, et al. Crit Rev Microbiol. 2017 Nov;43(6):779-798. doi: 10.1080/1040841X.2017.1313814. Epub 2017 Apr 25. Crit Rev Microbiol. 2017. PMID: 28440096 Free PMC article. Review.

• Lipids as modulators of membrane fusion mediated by viral fusion proteins.

  Teissier E, Pécheur EI. Teissier E, et al. Eur Biophys J. 2007 Nov;36(8):887-99. doi: 10.1007/s00249-007-0201-z. Epub 2007 Sep 19. Eur Biophys J. 2007. PMID: 17882414 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • EDP Sciences
  • Erudit

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program